Ledger.Open graph →

SEC Form D · filed August 9, 2019

BRAINSTORM CELL THERAPEUTICS INC

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NEW YORK, NY

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Ralph Kern · NEW YORK, NYExec Dr. Anthony Polverino · NEW YORK, NYDirector Chen Schor · Westminster, CODirector Arturo Araya · NEW YORK, NYExec Dr. June Almenoff · NEW YORK, NYDirector Dr. Irit Arbel · NEW YORK, NYDirector Malcolm Taub · NEW YORK, NYDirector Chaim Lebovits · NEW YORK, NYExec Eyal Rubin · NEW YORK, NYExec Uri Yablonka · NEW YORK, NYExec · Director Ralph Kern · NEW YORK, NYExec Dr. Anthony Polverino · NEW YORK, NYDirector Chen Schor · Hackensack, NJDirector Arturo Araya · NEW YORK, NYExec Dr. June Almenoff · NEW YORK, NYDirector Dr. Irit Arbel · NEW YORK, NYDirector Malcolm Taub · NEW YORK, NYDirector Chaim Lebovits · NEW YORK, NYExec Eyal Rubin · NEW YORK, NYExec Uri Yablonka · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗